Spearhead Capital Advisors, LLC Amicus Therapeutics, Inc. Transaction History

Spearhead Capital Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 28, 2022	SELL	$7.89 - $12.48 $281,104 - $444,637	-35,628 Closed	0 $0
Q4 2021 Jan 25, 2022	BUY	$9.82 - $12.44 $21,967 - $27,828	2,237 Added 6.7%	35,628 $412,000
Q3 2021 Oct 27, 2021	BUY	$8.74 - $11.84 $14,849 - $20,116	1,699 Added 5.36%	33,391 $319,000
Q2 2021 Aug 10, 2021	BUY	$8.71 - $10.72 $57,094 - $70,269	6,555 Added 26.08%	31,692 $306,000
Q1 2021 Apr 28, 2021	BUY	$9.2 - $23.86 $231,260 - $599,768	25,137 New	25,137 $248,000

312

314M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.75B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Spearhead Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Spearhead Capital Advisors, LLC with notifications on news.